AskVantage

Biotech and enhanced humans

This new imaging tech lets researchers see inside Cancer cells

All cancers are different and understanding how they interact with one another and their environment can make the difference between a patient living or dying.

Key takeaways

  • Led by the University of Surrey in the UK, the team sought to view and study the fatty contents (lipids) present within the cancer cells.
  • The technique was developed in collaboration with the University of College London and involves the pharmaceutical company GSK and the companies Yokogawa and Sciex.
  • Using Yokogawa’s Single Cellome System SS2000, individual cancer cells were sampled from a glass culture dish.
Cite or link to this article

Griffin, M. (2024) 'This new imaging tech lets researchers see inside Cancer cells', 311 Institute, 5 April. Available at: https://www.311institute.com/this-new-imaging-tech-lets-researchers-see-inside-cancer-cells/ (Accessed: 1 October 2026).

Following on from work that let scientists record living human cells in real time, and work that lets doctors use cells own proteins to record everything that happened within them, now scientists have identified a novel imaging technology that allows them to “see” inside a single living cancer cell and observe how it interacts with its surroundings.

Led by the University of Surrey in the UK, the team sought to view and study the fatty contents (lipids) present within the cancer cells. Lipids are key components of cells, it allows cancer cells specifically to grow, multiply, and metastasize.

The technique was developed in collaboration with the University of College London and involves the pharmaceutical company GSK and the companies Yokogawa and Sciex.

Using Yokogawa’s Single Cellome System SS2000, individual cancer cells were sampled from a glass culture dish. This innovative system extracts single live cells using tiny tubes, allowing for precise analysis. These tubes are barely 10 µm wide, half the diameter of the thinnest human hair.

In the next step, the cells were stained with fluorescent dye which enabled the researchers to monitor lipid droplets throughout the experiment.  Then, following this extensive procedure, the team collaborated with Sciex to create a novel mass spectrometry approach. This method allowed them to break the lipids and determine the cell’s actual makeup.

This entire process led to observing how cancer cells evolve in response to changes in their surroundings.

Johanna Von Gerichten, from Surrey’s School of Chemistry and Chemical Engineering, said that the trouble with cancer cells is that “no two are alike.”

“That makes it harder to design good treatment, because some cells will always resist treatment more than others. Yet it has always proven tricky to study live cells after they have been removed from their natural environment, in enough detail to truly understand their makeup,” Von Gerichten said.

“That is why it is so exciting to be able to sample live cells under a microscope and study their fatty contents one by one.”

The researchers further used this newly discovered approach to analyze the fatty lipid molecules within several cancer cells. Interestingly, the researchers identified differences in the lipid profiles of various cells.

“Our new method paves the way for studying cancer cells in detail we’ve never seen before. One day, we might be able to see how individual cancer cells communicate with their neighbours. That could unlock new, more targeted treatments,” said Carla Newman, Associate Director, Cellular Imaging and Dynamics at GSK in the press release.

This technique could provide valuable insights into how different types of cancer respond to treatments. It might also help doctors understand the impact of irradiation on cells, specifically how some cancer cells resist radiation treatment. This resistance may result in relapse of the cancer.

A deeper understanding of cancer biology may lead to the development of more effective treatments in the future.  Moreover, the researchers state that studying lipids inside single cells may help various health areas, including immunity, and infectious diseases.

The findings were published in the journal Analytical Chemistry.

FAQ

Why does this matter?

All cancers are different and understanding how they interact with one another and their environment can make the difference between a patient living or dying.

Matthew Griffin

About the author

Matthew Griffin Founder, 311 Institute

Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath."

Read full bio

Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath." 15-time best selling author of the "Codex of the Future" series, Matthew is the Founder and Futurist in Chief of the 311 Institute, a global Futures and Deep Futures advisory firm working with royal households, world leaders, G7, G20, and G77 governments, NGOs, and multi-national mid and mega cap firms to help them explore, shape, and lead the next 50 years of business and society.

An award-winning YouTube creator with over a million followers, with an unrivalled global reach and impact, Matthew is a highly sought-after international keynote speaker, lecturer, and mentor who collaborates with global leaders through the United Nations Alliance of Civilizations (UNAOC) and United Nations General Assembly (UNGA) to shape pivotal initiatives such as the UN’s AI for Humanity program, the United Nations Conference of the Parties (UN COP), and the World Economic Forum in Davos.

As the former Global Head of Cloud, National Security, and Enterprise Sales for companies including Atos, Dell-EMC, and IBM, Matthew has a proven track record of building multi-billion dollar business units and turning failing divisions into market leaders. His ability to identify, analyse, and communicate the implications of hundreds of emerging technologies and trends is unparalleled, and his insights are trusted by many of the world’s most respected organisations, including ABB, Accenture, Adidas, AON, ARM, BCG, Centrica, Citi, Coca-Cola, Dentons, Deloitte, Dow Jones, EY, Google, KPMG, Lego, Legal & General, LinkedIn, Microsoft, PepsiCo, Qualcomm, RWE, Samsung, Siemens AG and Siemens Energy, T-Mobile, UBS, VISA, Walmart, Workday, Worldpay and many others.

Regularly featured in the global media including the AP, BBC, Bloomberg, CNBC, Discovery, Forbes, Khaleej Times, Telegraph, TIME, ViacomCBS, WIRED, and the WSJ, Matthews mission is to help organisations create a fair and sustainable future whose benefits are shared by everyone irrespective of their ability, background, or circumstances.

What future do you need to see?

Choose one to get started on biotech and enhanced humans and the future of your organisation.

Where should Matthew reply?

Takes 30 seconds. No obligation. Matthew replies quickly. Privacy

Tag Cloud

Sources and further reading

  1. 2024 04 scientists lipids cell cancer phys.org
  2. Acs.analchem.3c05677 pubs.acs.org

Source: first published by the 311 Institute on 5 April 2024. Cite as: Griffin, M. (2024). This new imaging tech lets researchers see inside Cancer cells. 311 Institute. https://www.311institute.com/this-new-imaging-tech-lets-researchers-see-inside-cancer-cells/

You are welcome to quote this article with credit and a link to the original.

Book a Keynote